Last reviewed · How we verify

NCT06665789

Mindfulness-based Stress Reduction in Obese Women With Polycystic Ovary Syndrome (PICOS)

Completed NA Last updated 28 May 2025
What this trial tests

NA trial testing Mindfulness-based Stress Reduction in Obesity in 100 participants. Completed in 30 April 2025.

Timeline
31 October 2024
Primary endpoint
31 January 2025
30 April 2025

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment100
Start date31 October 2024
Primary completion31 January 2025
Estimated completion30 April 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

Adults 18 to 40, female only, with Obesity or Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to evaluate the effects of a mindfulness-based stress reduction (MBSR) program on Stress, depression, anxiety, cognitive triad and emotional appetite in obese women with polycystic ovary syndrome (PCOS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Mindfulness-based Stress Reduction

Trials testing the same drug.

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06665789.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing